Outside the Box
Recently I have come across a new EU directive that will likely have an impact to my processes. Although not the most recent update, directive 2010/32/EU comes into force within the UK on 11th May 2013 via the Health & Safety Regulations 2013.
Before you start rushing to re-check your lists of GMP & EU directive updates, 2010/32/EU has nothing to do with GMP, QP duties, API imports or falsified medicines. The aim of this directive is for the prevention of sharps injuries in the hospital and healthcare sector and one of the main recommendations is that needles must not be re-sheathed after use. This directly impacts some of our processes where we currently re-sheath needles during small scale aseptic manufacture to minimise contamination risks of the exposed needle.
Luckily the transposition into UK law has not been word-for-word. The UK regulations state '...re-sheathing must not occur unless justified by risk assessment....' whereas the original EU directive text states '...the practice of re-capping (re-sheathing) shall be banned with immediate effect....'. Therefore the UK regulations provides some 'wriggle room' to continue to re-sheath providing this is justified via risk assessment. Now this is unlikely to come under the remit of GMP inspections but Hospital Trusts within the UK do get audited by the Health & Safety Executive and hence may request to view these risk assessments at some point in the future.
I realise that this will not have a direct impact to commercial QPs but I wanted to raise it for the following reasons:
- To ensure you are aware of all legislative updates that may affect your practice, not just GMP related ones -cast your net far and wide.
- Legal duties '..products manufactured & checked in accordance with the laws in force in the member state...' therefore covers all types of legislation within the UK (including Health & Safety Law)
- An example of how EU directives are not always transposed word-for-word into UK law.
- For an awareness of other areas of practice within pharmaceutical manufacturing
- The importance of knowing your manufacturing processes
Summary
During your viva I think it is important to know the all the important GMP updates and these would be first on my list - (i.e. my first layer). However, I also believe that being able to demonstrate an awareness of other legislation that has a direct impact to your area of practice will score some points with the assessors. Anyone can learn all the updates parrot fashion but is that really what the assessors are looking for?
I hope this illustrates that keeping up-to-date is not just about GMP updates. Yes, those are extremely important to both trainee & qualified QPs but you still need an awareness of those legislative updates outside the GMP box. Your legal duties as stated in Article 51 clearly state that each batch needs to be manufactured in accordance with the local laws of the member state.
Another interesting point for another post is that Schedule 7 SI2012/1916 doesn't refer to 'local laws' only 'these regulations' ie only the Human Medicines Regs 2012. Do you therefore need to comply with Health & Safety legislation...? Do let me know your thoughts on this